Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches

AYDİL, Utku

Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches

Utku AYDİL (Gazi Üniversitesi Tıp Fakültesi, Kulak Burun Boğaz ve Hastalıkları Anabilim Dalı, Ankara, Türkiye)

Türk Otorinolarengoloji Arşivi

0 0

Yıl: 2015 Cilt: 53 Sayı: 1 Sayfa Aralığı: 26 - 31 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches

Öz:

Son yıllarda, ileriye dönük çalışmalar ve ilişkili algoritmalar üzerine kurulu olan kanıta dayalı tıp altın dönemini yaşamaktadır. Tıbbi bilgi son birkaç dekatta daha önce hiç görülmediği kadar sistematik olarak üretilmiş, kategorize edilmiş ve yaygınlaşmıştır. Bu durumun ger- çekleşmesinde önemli bir faktör de iletişim olanakları- nın genişlemesidir. Baş-boyun kanserlerinin tedavi alanı da bu gelişmelerden etkilenmiş ve yüksek kanıt düzeyindeki çalışmalar tedavi stratejilerinin temelini oluşturmaya başlamıştır. Ne var ki bu çalışmaların hemen hemen tümü cerrahi dışı uygulamalar ile ilgilidir ve baş-boyun kanserlerinin cerrahi tedavisi ile ilgili yüksek kanıt de- ğerindeki çalışmalara çok fazla rastlanmamaktadır. Bu yazıda baş-boyun kanserleri ile ilgili önemli çalışmalar ve sonuçları değerlendirilmektedir.

Anahtar Kelime:

Konular: Kulak, Burun, Boğaz

Baş Boyun Kanserleri Hakkında Dönüm Noktası Olan Güncel Çalışmalar: Modern Tedavi Yaklaşımlarının Kanıta Dayalı Temelleri

Öz:

Evidence-based medicine, established on prospectivestudies and related algorithms is living its golden agein recent years. Within the last few decades, medicalknowledge has been systematically produced, categorized,and spread in a way never seen before. Oneof the most important factors in realizing this situationis the expansion of the communication facilities.The area of the management of head and neck cancerswas also affected by these advances, and studieswith high-level evidence became the mainstay in thedetermination of the management strategies. However,probably almost all of these studies are aboutnon-surgical modalities, and studies with high-levelevidence regarding the surgical treatment of head andneck cancers are scarce. In this paper, important studieson head and neck cancers and their results will bereviewed.

Anahtar Kelime:

Konular: Kulak, Burun, Boğaz

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996; 312: 71-2. [CrossRef ]
2. Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009) (cited 2014 August 5) Available from: http://www. cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.
3. Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004; 170: 477-80.
4. Julian DG. What is right and what is wrong about evidence-based medicine? J Cardiovasc Electrophysiol 2003; 14 (9 Suppl): S2-5. [CrossRef ]
5. Bachar G, Gullane PJ, Irish JC. Future developments in head and neck cancer therapy. In: Montgomery PQ, Evans PHR, Gullane PJ, editors. Principles and practice of head and surgery and oncology (second edition). UK: Informa Healthcare; 2009. p.230-45. [CrossRef ]
6. Maluf FC, Sherman E, Pfister DG. Chemotherapy and chemoprevention in head and neck Cancer. In: Shah JP, editor. Cancer of the head and neck. Hamilton: BC Decker; 2001. p.444-66.
7. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114: 806-16. [CrossRef ]
8. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-90. [CrossRef ]
9. Karp DD, Vaughan CW, Carter R, Willett B, Heeren T, Calarese P, et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report. Am J Clin Oncol 1991; 14: 273-9. [CrossRef ]
10. Demard F, Chauvel P, Santini J, Vallicioni J, Thyss A, Schneider M. Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck 1990; 12: 225-31. [CrossRef ]
11. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-8. [CrossRef ]
12. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, , Pajak TF, et al. Long-term results of RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013; 31: 845-52. [CrossRef ]
13. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al; Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-44. [CrossRef ]
14. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al; European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-52. [CrossRef ]
15. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-78. [CrossRef ]
16. Denaro N, Russi EG, Lefebvre JL, Merlano MC. A systematic review of current and emerging approaches in the field of larynx preservation. Radiother Oncol 2014; 110: 16-24. [CrossRef ]
17. Mak MP, Glisson BS. Is there still a role for induction chemotherapy in locally advanced head and neck cancer? Curr Opin Oncol 2014; 26: 247-51. [CrossRef ]
18. Bernier J. Current state-of-the-art for concurrent chemoradiation. Semin Radiat Oncol 2009; 19: 3-10. [CrossRef ]
19. Paccagnella A, Ghi MG, Loreggian L, Buffoli A, Koussis H, Mione CA, et al; Gruppo di Studio Tumori della Testa e del Collo XRP 6976 F/2501 Study. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol 2010; 21: 1515-22. [CrossRef ]
20. Haddad R, O’Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 2013; 14: 257-64. [CrossRef ]
21. Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, et al. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol 2014; 32: 2735-43. [CrossRef ]
22. Loo SW, Geropantas K, Roques TW. Functional organ preservation in locally advanced laryngeal squamous cell carcinoma: is there a role for induction chemotherapy? Clin Oncol (R Coll Radiol) 2013; 25: 298-307. [CrossRef ]
23. Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, et al. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d’Oncologia in stage III larynx carcinoma. Laryngoscope 2006; 116: 1651-6. [CrossRef ]
24. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al; EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357: 1695-704. [CrossRef ]
25. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al; TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007; 357: 1705-15. [CrossRef ]
26. Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005; 23: 8636-45. [CrossRef ]
27. Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009; 101: 498-506. [CrossRef ]
28. Zhong LP, Zhang CP, Ren GX, Guo W, William WN Jr, et al. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus upfront surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 2013; 31: 744-51. [CrossRef ]
29. Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, et al. EORTC Head and Neck Cancer Cooperative Group; EORTC Radiation Oncology Group. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 2009; 101: 142-52. [CrossRef ]
30. Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, et al. Eastern Cooperative Oncology Group. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2005; 23: 3562-7. [CrossRef ]
31. Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol 2012; 13: 145-53. [CrossRef ]

APA	AYDİL U (2015). Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. , 26 - 31.
Chicago	AYDİL Utku Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. (2015): 26 - 31.
MLA	AYDİL Utku Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. , 2015, ss.26 - 31.
AMA	AYDİL U Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. . 2015; 26 - 31.
Vancouver	AYDİL U Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. . 2015; 26 - 31.
IEEE	AYDİL U "Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches." , ss.26 - 31, 2015.
ISNAD	AYDİL, Utku. "Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches". (2015), 26-31.

APA	AYDİL U (2015). Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. Türk Otorinolarengoloji Arşivi, 53(1), 26 - 31.
Chicago	AYDİL Utku Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. Türk Otorinolarengoloji Arşivi 53, no.1 (2015): 26 - 31.
MLA	AYDİL Utku Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. Türk Otorinolarengoloji Arşivi, vol.53, no.1, 2015, ss.26 - 31.
AMA	AYDİL U Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. Türk Otorinolarengoloji Arşivi. 2015; 53(1): 26 - 31.
Vancouver	AYDİL U Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches. Türk Otorinolarengoloji Arşivi. 2015; 53(1): 26 - 31.
IEEE	AYDİL U "Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches." Türk Otorinolarengoloji Arşivi, 53, ss.26 - 31, 2015.
ISNAD	AYDİL, Utku. "Recent Landmark Studies on Head and Neck Cancers: Evidence-Based Fundamentals of Modern Therapeutic Approaches". Türk Otorinolarengoloji Arşivi 53/1 (2015), 26-31.